Mast Therapeutics, Inc. (MSTX)

[cherrydrpepper]

This R/S is great news! It's great news for two reasons. First, it allows us to keep our AMEX listing - extremely important to shareholder value and company PR. Second, as astute stated by someone early, the magnitude of the R/S will allow us to jump to around the $5 mark. This is the base mark for big investors, who we are trying to draw in once we brush FDA approval. This is a very strategic and well-timed move on the part of ANX. It is obvious that they waited until this point - imminent meeting with FDA within 2 weeks!!!